European Archives - Page 278 of 1107 - European Medical Journal

Proteomics Identifies Early Biomarkers for Hepatocellular Carcinoma

Research highlights the potential of proteomics in early detection of hepatocellular carcinoma and improving diagnostic accuracy.

New Surgical Platform Rapidly Identifies Isocitrate Dehydrogenase Mutations in Gliomas

A study reports of a new surgical platform capable of identifying isocitrate dehydrogenase mutations in gliomas in under two minutes.

Perioperative FLOT Outperforms Neoadjuvant Chemoradiation in Esophageal Cancer Survival

A recent study found that perioperative FLOT chemotherapy significantly improves survival rates in patients with esophageal adenocarcinoma.

AI Enhances Screening Accuracy and Reduces Radiologist Workload

Artificial intelligence (AI) significantly decreases’ radiologists’ workload while improving the accuracy of breast cancer screenings, a recent study has reported.

Active Childhood Reduces Risk of Liver Disease in Adulthood

A recent study has highlighted the importance of physical activity from childhood in preventing liver disease in young adulthood.

Tattoo Exposure Linked to Increased Lymphoma Risk

A recent study has highlighted a potential link between tattoo exposure and an increased risk of malignant lymphoma.

Impact of Bariatric Surgery on Clinical Outcomes in Metabolic Liver Disease

New data reveals that bariatric surgery is linked to improvements in clinical outcomes for patients with metabolic dysfunction-associated steatotic liver disease.

Parental Obesity Linked With Metabolic Dysfunction-Associated Steatotic Liver Disease

New findings demonstrate that the risk of MASLD in early adulthood increased in children born to overweight parents.

IMROZ Multiple Myeloma Study Results: Abstracts from ASCO 2024

Read results from a trial presented as ASCO 2024, which details the impact that Isa-VRd therapy has in multiple myeloma patients

Durvalumab as Consolidation Treatment in ADRIATIC Trial: Abstracts from ASCO 2024 Plenary Session

Read the latest news from ASCO 2024, including on results from the ADRIATIC trial on small-cell lung cancer post-chemoradiotherapy.